[A new antitubercular agent: rifampicin].
D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004361:Drug Tolerance; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012293:Rifampin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000995:Antitubercular Agents; D012293:Rifampin
Un nouveau médicament antituberculeux: la rifampicine.